Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Calcium channel blocker
by Highest Patent Value in the China in 2020

The Calcium channel blocker top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Calcium channel blocker Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are a group of medications that disrupt the movement of calcium (Ca²⁺) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
#
Company Name
Region
Tech Topics
Total
1
Biology,Medicine,Health care,
...[+2]
Avg patent value: 2.86 M
2
Avg patent value: 1.91 M
3
Avg patent value: 96,500
4
Avg patent value: 95,000
5
Gastroenterology,Health care,Medicine,
...[+2]
Avg patent value: 93,000
6
Avg patent value: 77,000
7
Avg patent value: 62,000
8
Avg patent value: 62,000
9
Avg patent value: 53,000
10
Avg patent value: 49,000
11
Avg patent value: 36,000
12
Avg patent value: 22,000
13
Avg patent value: 3,533
14
Avg patent value: 3,500
15
Avg patent value: 0
16
Avg patent value: 0
17
Avg patent value: 0
18
Avg patent value: 0
19
Shanghai Innostar Biotechnology Co Ltd
Avg patent value: 0
20
Avg patent value: 0
Page generation time: Jun 30 2025